WELL.ME - Wellbeing therapy based on real-time personalized mobile architecture, vs. cognitive therapy, to reduce psychological distress and promote healthy lifestyle in cardiovascular disease patients: study protocol for a randomized controlled trial

Trials

Michele Carenini⁵  Efstathopoulos Efstathios⁷  Enzo Grossi²  Enrico Molinari¹  Wendy Moreno Peña⁴  Vontas Apostolos⁶  Vassilis Kouloulias⁷  Angelo Compare³ 

[1] Istituto Auxologico Italiano; Catholic University of Milan, Milan, Italy;Medical Department, Bracco SpA; IULM - University, Fondazione Bracco, Milan, Italy;Human Factors and Technologies for Health - HTC Centre; Dept. of Human and Social Sciences, University of Bergamo, Piazzale S. Agostino 2, 24129, Bergamo, BG, Italy;SOROS GABINETE, Socia ProgramasEuropeos, Europe, Spain;NoemaLife Spa, Bologna, Italy;Technopolis ICT Business Park, Thessaloniki, Greece;Medical School, National University of Athens, Athens, Greece

关键词: Cardiac disease;    Mobile technology;    Wellbeing therapy;    Cognitive behavior therapy;    Psychological distress;    Depression;    Anxiety;   

Others  :  1095355
DOI  :  10.1186/1745-6215-13-157

 received in 2012-03-04, accepted in 2012-07-17,  发布年份 2012

【 摘 要 】

Background

There is compelling evidence that psychological factors may have the same or even greater impact on the possibility of adverse events on cardiac diseases (CD) than other traditional clinical risk factors. Anxiety and depression are predictors of short- and long-term adverse outcomes, increased risk for higher rates of in-hospital complications, re-infarction, malignant arrhythmias, and mortality in CD patients. Despite researchers finding that cognitive behavior therapy (CBT) reduced depressive and anxiety symptoms, the fact that such results are maintained only in the short term and the lack of maintenance of the long-term affects the absence of changes in lifestyles, preventing the possibility of a wide generalization of results. Recently wellbeing therapy (WBT) has been proposed as a useful approach to improve healthy lifestyle behaviors and reduce psychological distress.

Methods/design

The present randomized controlled study will test WBT, in comparison with CBT, as far as the reduction of symptoms of depression, anxiety and psychological distress, and the improvement of lifestyle behaviors and quality of life in cardiac patients are concerned. Moreover, innovations in communication technologies allow patients to be constantly followed in real life. Therefore WBT based on personalized mobile technology will allow the testing of its effectiveness in comparison with usual WBT.

Discussion

The present study is a large outpatient study on the treatment of co-morbid depression, anxiety, and psychological distress in cardiac patients. The most important issues of this study are its randomized design, the focus on promotion of health-related behaviors, and the use of innovative technologies supporting patients’ wellbeing in real life and in a continuous way. First results are expected in 2012.

Trial registration

ClinicalTrials.gov Identifier: NCT01543815.

【 授权许可】

   
2012 Compare et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Kubzansky LD, Kawachi I: Going to the heart of the matter: do negative emotions cause coronary heart disease? J Psychosom Res 2000, 48:323-337.
• [2]Rozanski A, Blumenthal JA, Kaplan J: Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999, 99:2192-2217.
• [3]Molinari E, Compare A, Parati G: Clinical psychology and heart disease. New York: Springer; 2006.
• [4]Compare A, Germani E, Proietti R, Janeway D: Clinical psychology and cardiovascular disease: an up-to-date clinical practice review for assessment and treatment of anxiety and depression. Clin Pract Epidemiol Mental Health 2011, 7:148-156.
• [5]Barefoot JC, Helms MJ, Mark DB, Blumenthal JA, Califf RM, Haney TL, O’Connor CM, Siegler IC, Williams RB: Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996, 78:613-617.
• [6]Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, Blazing MA, Davenport C, Califf RM, Krishnan RR, O’Connor CM: Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001, 161:1849-1856.
• [7]Zuidersma M, Thombs BD, de Jonge P: Onset and recurrence of depression as predictors of cardiovascular prognosis in depressed acute coronary syndrome patients: asystematic review. Psychother Psychosom 2011, 80:227-237.
• [8]Janszky I, Ahnve S, Lundberg I, Hemmingsson T: Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men. J Am Coll Cardiol 2010, 56:31-37.
• [9]Whang W, Shimbo D, Kronish IM, Duvall WL, Julien H, Iyer P, Burg MM, Davidson KW: Depressive symptoms and all-cause mortality in unstable angina pectoris (from the Coronary Psychosocial Evaluation Studies [COPES]). Am J Cardiol 2010, 106:1104-1107.
• [10]Nabi H, Shipley MJ, Vahtera J, Hall M, Korkeila J, Marmot MG, Kivimaki M, Singh-Manoux A: Effects of depressive symptoms and coronary heart disease and their interactive associations on mortality in middle-aged adults: the Whitehall II cohort study. Heart 2010, 96:1645-1650.
• [11]Watkins LL, Blumenthal JA, Babyak MA, Davidson JR, McCants CB Jr, O’Connor C, Sketch MH Jr: Phobic anxiety and increased risk of mortality in coronary heart disease. Psychosom Med 2010, 72:664-671.
• [12]Haworth JE, Moniz-Cook E, Clark AL, Wang M, Waddington R, Cleland JG: Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction. Eur J Heart Fail 2005, 7:803-808.
• [13]Jiang W, Kuchibhatla M, Cuffe MS, Christopher EJ, Alexander JD, Clary GL, Blazing MA, Gaulden LH, Califf RM, Krishnan RR, O’Connor CM: Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation 2004, 110:3452-3456.
• [14]Falk K, Patel H, Swedberg K, Ekman I: Fatigue in patients with chronic heart failure - a burden associated with emotional and symptom distress. Eur J Cardiovasc Nurse 2009, 8:91-96.
• [15]Scherer M, Himmel W, Stanske B, Scherer F, Koschack J, Kochen MM, Herrmann-Lingen C: Psychological distress in primary care patients with heart failure: a longitudinal study. Br J Gen Pract 2007, 57:801-807.
• [16]Tsuchihashi-Makaya M, Kato N, Chishaki A, Takeshita A, Tsutsui H: Anxiety and poor social support are independently associated with adverse outcomes in patients with mild heart failure. Circ J 2009, 73:280-287.
• [17]Friedmann E, Thomas SA, Liu F, Morton PG, Chapa D, Gottlieb SS: Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. Am Heart J 2006, 152:940. e1-8
• [18]Kubzansky LD, Kawachi I, Weiss ST, Sparrow D: Anxiety and coronary heart disease: a synthesis of epidemiological, psychological, and experimental evidence. Ann Behav Med 1998, 20:47-58.
• [19]Moser DK, Dracup K: Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events? Psychosom Med 1996, 58:395-401.
• [20]Manzoni GM, Villa V, Compare A, Castelnuovo G, Nibbio F, Titon AM, Molinari E, Gondoni LA: Short-term effects of a multi-disciplinary cardiac rehabilitation programme on psychological well-being, exercise capacity and weight in a sample of obese in-patients with coronary heart disease: a practice-level study. Psychol Health Med 2011, 16:178-189.
• [21]Lesperance F, Frasure-Smith N, Koszycki D, Laliberte MA, van Zyl LT, Baker B, Swenson JR, Ghatavi K, Abramson BL, Dorian P, Guertin MC, CREATE Investigators: Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007, 297:367-379.
• [22]Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Raczynski JM, Schneiderman N, Enhancing Recovering in Coronary Heart Disease Patients Investigators (ENRICHD): Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery In Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003, 289:3106-3116.
• [23]Barlow DH, Gorman JM, Shear MK, Woods SW: Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA 2000, 283:2529-2536.
• [24]Gary RA, Dunbar SB, Higgins MK, Musselman DL, Smith AL: Combined exercise and cognitive behavioral therapy improves outcomes in patients with heart failure. J Psychosom Res 2010, 69:119-131.
• [25]Ryff CD: In the eye of the beholder: views of psychological well-being among middle-aged and older adults. Psychological Aging 1989, 4:195-201.
• [26]Ruini C, Fava GA: Well-being therapy for generalized anxiety disorder. J Clin Psychol 2009, 65:510-519.
• [27]Fava GA, Ruini C, Rafanelli C, Finos L, Salmaso L, Mangelli L, Sirigatti S: Well-being therapy of generalized anxiety disorder. Psychother Psychosom 2005, 74:26-30.
• [28]Fava GA, Ruini C: Development and characteristics of a well-being enhancing psychotherapeutic strategy: well-being therapy. J Behav Ther Exp Psychiatry 2003, 34:45-63.
• [29]Fava GA, Rafanelli C, Tomba E, Guidi J, Grandi S: The sequential combination of cognitive behavioral treatment and well-being therapy in cyclothymic disorder. Psychother Psychosom 2011, 80:136-143.
• [30]Beck AT, Rush AJ, Shaw BF, Emery G: Cognitive therapy of depression. New York, NY: Guilford Press; 1979.
• [31]Spitzer RL, Kroenke K, Williams JB: Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999, 282:1737-1744.
• [32]Lamers F, Jonkers CC, Bosma H, Penninx BW, Knottnerus JA, van Eijk JT: Summed score of the Patient Health Questionnaire-9 was a reliable and valid method for depression screening in chronically ill elderly patients. J Clin Epidemiol 2008, 61:679-687.
• [33]Lowe B, Decker O, Muller S, Brahler E, Schellberg D, Herzog W, Herzberg PY: Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Medical Care 2008, 46:266-274.
• [34]Fava GA, Freyberger HJ, Bech P, Christodoulou G, Sensky T, Theorell T, Wise TN: Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995, 63:1-8.
• [35]Sonino N, Fava GA: A simple instrument for assessing stress in clinical practice. Postgrad Med J 1998, 74:408-410.
• [36]Ware J Jr, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical Care 1996, 34:220-233.
• [37]Demoly P, Gueron B, Annunziata K, Adamek L, Walters RD: Update on asthma control in five European countries: results of a 2008 survey. Eur Respir Rev 2010, 19:150-157.
• [38]Dupuy HJ: The Psychological General Well-being (PGWB) Index. In Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. Edited by Wenger NK, Mattson ME, Furburg CD, Elinson J. New York, NY: Le Jacq Publishing; 1990:170-183.
• [39]Grossi E, Groth N, Mosconi P, Cerutti R, Pace F, Compare A, Apolone G: Development and validation of the short version of the Psychological General Well-Being Index (PGWB-S). Health Qual Life Outcomes 2006, 4:88. BioMed Central Full Text
• [40]Omvik P, Thaulow E, Herlan O, Eide I, Midha R, Turner R: Double-blind, parallel, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicenter study. J Hypertens 1993, 11:103-113.
• [41]Rector TS, Cohn JN: Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J 1992, 124:1017-1025.
• [42]Cohen J: Statistical power analysis for the behavioural sciences. 2nd edition. Hillsdale, NJ: Erlbaum; 1988.